Philips has said that it has reached an agreement in principle with the U.S. Department of Justice related to the sleep apnea case. The technological medical group is expected to pay around 288 million euros to end the criminal and civil proceedings related to the large-scale recall of the sleep apnea devices, Philips stated in its quarterly figures. “The settlement is dependent on the completion of the relevant documentation; payment is expected in the first quarter of 2027,” Philips stated.